Zenas BioPharma’s (ZBIO) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Zenas BioPharma (NASDAQ:ZBIO – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $44.00 target price on the stock. A number of other analysts have also recently weighed in on the company. Wall Street Zen cut Zenas BioPharma from a “hold” […]
13 Feb 06:08 · The Markets Daily